Randomized, double-blind, placebo-controlled study of safety and efficacy of miltefosine in antihistamine-resistant chronic spontaneous urticaria.

Research output: Contribution to journal › Research article › Contributed › peer-review

Contributors

  • M. Magerl - (Author)
  • M. Rother - (Author)
  • T. Bieber - (Author)
  • T. Biedermann - (Author)
  • J. Brasch - (Author)
  • R. Dominicus - (Author)
  • N. Hunzelmann - (Author)
  • T. Jakob - (Author)
  • V. Mahler - (Author)
  • G. Popp - (Author)
  • K. Schäkel - (Author)
  • R. Schlingensiepen - (Author)
  • J. Schmitt - (Author)
  • F. Siebenhaar - (Author)
  • J.C. Simon - (Author)
  • P. Staubach - (Author)
  • B. Wedi - (Author)
  • C. Weidner - (Author)
  • M. Maurer - (Author)

Details

Original languageEnglish
JournalJournal of the European Academy of Dermatology and Venereology
Volume27
Issue number3
Publication statusPublished - 29 Aug 2012
Peer-reviewedYes

External IDs

Scopus 84874113715

Keywords